Christoffer Tell - Newbury Pharmaceuticals Chief Officer
NEWBRY Stock | 3.44 0.08 2.38% |
Insider
Christoffer Tell is Chief Officer of Newbury Pharmaceuticals AB
Age | 36 |
Phone | 46 46 12 11 20 |
Web | https://www.newburypharma.com |
Similar Executives
Found 2 records | INSIDER Age | ||
Christine Ryan | Gabather AB | N/A | |
MichaelRobin Witt | Gabather AB | N/A |
Management Performance
Return On Equity | -0.34 | |||
Return On Asset | -0.16 |
Newbury Pharmaceuticals Leadership Team
Elected by the shareholders, the Newbury Pharmaceuticals' board of directors comprises two types of representatives: Newbury Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Newbury. The board's role is to monitor Newbury Pharmaceuticals' management team and ensure that shareholders' interests are well served. Newbury Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Newbury Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrea Karnitschky, Sr Devel | ||
Fredrik Hellqvist, VP Marketing | ||
Karl Karlsson, Founder Chairman | ||
Lars Minor, Chief Officer | ||
Christoffer Tell, Chief Officer |
Newbury Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Newbury Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.34 | |||
Return On Asset | -0.16 | |||
Profit Margin | (2.89) % | |||
Operating Margin | (2.75) % | |||
Current Valuation | 96.57 M | |||
Shares Outstanding | 19.52 M | |||
Shares Owned By Insiders | 78.64 % | |||
Shares Owned By Institutions | 6.72 % | |||
Price To Book | 1.86 X | |||
Price To Sales | 25.09 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Newbury Stock
Newbury Pharmaceuticals financial ratios help investors to determine whether Newbury Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Newbury with respect to the benefits of owning Newbury Pharmaceuticals security.